David Jonathan Cohen, MD
Medical Director, Renal Transplantation
I am involved in numerous clinical protocols investigating new immunosuppressive drugs and/or new combinations of existing medications in renal transplant patients, both newly transplanted patients and those with long-term functioning transplants.
Wilkinson AH, Cohen DJ. (1999) Renal failure in recipients of non-renal solid organ transplants. J Amer Soc Nephrol 10:1136-45
The Mycophenolate Mofetil Acute Rejection Study Group. (2001) Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. Transplantation 71:1091-7
Lin J, Valeri AM, Cohen DJ, Radhakrishnan J. (2002) Angiotensin converting enzyme (ACE) inhibition in chronic allograft nephropathy. Transplantation 73:783-8
Adams PL, Cohen DJ, Danovitch GM, et al. (2002) The nondirected live-kidney donor: ethical considerations and practice guidelines. Transplantation 74:582-90